DiaMedica Therapeutics Inc. - COM NEW (DMAC)

Historical Portfolio Holders from Q4 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
5.58M
Holdings value Q3 2024
$23.3M
Value change Q3 2024
+$2.25M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
40
Number of buys Q3 2024
21
Number of sells Q3 2024
-9
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 5.58M $23.3M +$2.25M $4.19 40
2024 Q2 5.06M $14.9M +$1.37M $2.95 32
2024 Q1 4.6M $12.7M +$2.07M $2.77 31
2023 Q4 3.84M $10.9M -$629K $2.84 36
2023 Q3 4.25M $11M +$1.92M $2.58 35
2023 Q2 3.49M $15.1M +$4.15M $4.32 29
2023 Q1 2.57M $3.92M +$61.6K $1.53 21
2022 Q4 2.52M $3.99M -$6.54K $1.58 26
2022 Q3 2.53M $3.13M -$2.36M $1.24 22
2022 Q2 3.67M $7.41M -$802K $2.02 24
2022 Q1 4.01M $10M -$428K $2.50 27
2021 Q4 3.99M $14.9M +$4.43M $3.73 33
2021 Q3 2.8M $11.2M -$4.24M $4.01 31
2021 Q2 3.78M $16.9M -$48.6M $4.45 36
2021 Q1 5.69M $88.1M +$33.2M $9.15 36
2020 Q4 5.98M $60.5M +$20.7K $10.14 32
2020 Q3 6.7M $28.4M +$15.5M $4.24 29
2020 Q2 3.03M $21M +$1.23M $6.93 19
2020 Q1 2.92M $8.23M +$5.98M $2.80 17
2019 Q4 801K $3.89M -$426K $4.85 12
2019 Q3 957K $1.98M -$928K $2.07 14
2019 Q2 1.28M $6.37M +$1.45M $4.96 14
2019 Q1 1.01M $4.6M +$283K $4.54 10
2018 Q4 1.03M $3M +$3M $2.91 7